House
Sign inCreate account
Drug lookup
Drug reference

nefopam

benzoxazocine derivative, nonopioid analgesic · analgesic

benzoxazocine derivative, nonopioid analgesicanalgesic
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated

Mechanism

Nefopam is a nonopioid analgesic that does not inhibit prostaglandin synthesis.

Indications

traumatic painpostoperative painshort-lasting musculoskeletal painpain persistent and not adequately relieved by other analgesics

Dosing

Adult
30–60 mg TDS oral, 20 mg i.m. 6 hourly

Contraindications

  • epileptics

Side effects

Common
nausea (often dose limiting)
Serious
  • anticholinergic effects (dry mouth, urinary retention, blurred vision)
  • sympathomimetic effects (tachycardia, nervousness)

Related guidelines

Drug-resistant tuberculosis
RNTCP · Pulmonology · 2025
Latent tuberculosis infection
RNTCP · Infectious Disease · 2023

Ask House about nefopam

Continue into a citation-backed clinical answer with the drug context already attached.

Open in workspaceAsk House about this drug

Sources: KD Tripathi 7e·Verified: 2026-05-10 · House clinical team